A Comparative Study of Effects of Antiproliferative Drugs on Human Retinal Pigment Epithelial Cells in Vitro
- 1 June 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 18 (3) , 251-264
- https://doi.org/10.1089/108076802760116179
Abstract
The effects of various antiproliferative drugs have been tested in numerous cell types in vitro, but a comparison of effects of these drugs on cultured human retinal pigment epithelium (RPE) has not been reported. We studied the effects of four most widely used antiproliferative drugs (5-FU, daunomycin, mitomycin and dexamethasone) in a new in vitro model system (cultured human RPE). Various concentrations and exposure periods were tested in four human RPE cell lines. 5-FU showed a dose-dependant growth inhibition, with an ID50 of 5.35 ± 2.38 × 10-7 M after 4 days culture. A decrease of cell number occurred relatively later, the slope of the dose-response curve was less steep than that of others. Mitomycin C showed an immediate and strong growth inhibition and cytotoxic effects, with an ID50 of 3.73 ± 0.71 × 10-9 M. RPE cultured with daunomycin showed an abrupt decrease of cell number from 10-9 M to 10-8 M, the ID value was 1.07 ± 0.23 × 10-8 M. Dexamethasone showed a biphasic effect; it stimulated cell growth at 10-7 to 10-6 M and inhibited cell growth at 10-4 M or higher, with an ID50 of 6.05 ± 1.61 × 10-3 M. The advantages and disadvantages of these drugs and the prospective clinical application of these drugs for management of proliferative vitreoretinopathy (PVR) were discussed. Development of an in vitro model using cultured human RPE to study the effects of various antiproliferative drugs can provide a rapid, safe and inexpensive method for selection of drugs used for management of proliferative vitreoretinopathy.Keywords
This publication has 27 references indexed in Scilit:
- Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trialAmerican Journal of Ophthalmology, 1998
- Proliferative VitreoretinopathySurvey of Ophthalmology, 1998
- THERAPEUTIC EFFECT OF PERIOCULAR CORTICOSTEROIDS IN EXPERIMENTAL PROLIFERATIVE VlTREORETINOPATHYPublished by Wolters Kluwer Health ,1997
- An Immunohistochemical StudyRetina, 1992
- Cellular components of subretinal membranes in proliferative vitreoretinopathyEye, 1989
- PROLIFERATIVE VITREORETINOPATHYRetina, 1987
- Proliferative vitreoretinopathy and chemotherapeutic agentsSurvey of Ophthalmology, 1985
- Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study.British Journal of Ophthalmology, 1984
- ANTIPROLIFERATIVE DRUGS IN THE TREATMENT OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHYRetina, 1983